Check Credit Score
Check Credit Score
HomeNewsIndia

Coronavirus update: India records 1,61,736 COVID-19 cases, 879 deaths

Coronavirus update: The death toll increased to 1,71,058 with 879 new fatalities, the data updated at 8 am showed.

April 13, 2021 / 09:59 AM IST
Coronavirus

Coronavirus

A total of 1,61,736 new coronavirus infections have been reported in a day pushing India's tally of cases to 1,36,89,453, while the national COVID-19 recovery rate dropped further to 89.51 percent, according to data updated by the Union Health Ministry on Monday.

The death toll increased to 1,71,058 with 879 new fatalities, the data updated at 8 am showed.

Registering a steady increase for the 34th day in a row, the number of active cases rose to 12,64,698, or 9.24 percent of the total infections. The active caseload was at its lowest at 1,35,926 on February 12, 2021 and it was at its highest at 10,17,754 on September 18, 2020.

The number of people who have recuperated from the disease surged to 1,22,53,697, while the case fatality rate has dropped further to 1.25 percent, the data stated.

India's COVID-19 tally had crossed the 20-lakh mark on August 7; 30 lakh on August 23; 40 lakh on September 5; and 50 lakh on September 16. It went past 60 lakh on September 28; 70 lakh on October 11; 80 lakh on October 29; 90 lakh on November 20; and the one-crore mark on December 19.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

According to the Indian Council of Medical Research (ICMR), 25,92,07,108 samples have been tested up to April 12, of which 14,00,122 were done on Monday.

(With PTI inputs)

Moneycontrol News
first published: Apr 13, 2021 09:52 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347